90 related articles for article (PubMed ID: 1495942)
1. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types.
Rutgers JL; Bell DA
Mod Pathol; 1992 Jul; 5(4):367-71. PubMed ID: 1495942
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
[TBL] [Abstract][Full Text] [Related]
3. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
Gaggero G; Sola S; Mora M; Fulcheri E
Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
[TBL] [Abstract][Full Text] [Related]
4. Mucin histochemistry of ovarian borderline tumors of mucinous and mixed-epithelial types.
Rutgers JL; Baergen RN
Mod Pathol; 1994 Oct; 7(8):825-8. PubMed ID: 7838836
[TBL] [Abstract][Full Text] [Related]
5. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
6. Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary.
Halimi SA; Maeda D; Shinozaki-Ushiku A; Koso T; Matsusaka K; Tanaka M; Arimoto T; Oda K; Kawana K; Yano T; Fujii T; Fukayama M
Histopathology; 2013 Oct; 63(4):534-44. PubMed ID: 23905715
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
8. S-100 protein in ovarian tumors. A comparative immunohistochemical study of 135 cases.
Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
Acta Pathol Jpn; 1991 Mar; 41(3):233-9. PubMed ID: 2068948
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
10. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
11. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
de Nictolis M; Montironi R; Tommasoni S; Valli M; Pisani E; Fabris G; Prat J
Int J Gynecol Pathol; 1994 Jan; 13(1):10-21. PubMed ID: 8112952
[TBL] [Abstract][Full Text] [Related]
12. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical demonstration of CA 125, CA 19-9 and CEA in normal and pathologically changed adnexa].
Neunteufel W; Breitenecker G
Geburtshilfe Frauenheilkd; 1988 May; 48(5):334-7. PubMed ID: 3165079
[TBL] [Abstract][Full Text] [Related]
14. Mucinous tumors of the ovary: a review.
Hart WR
Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
[TBL] [Abstract][Full Text] [Related]
15. [Histogenetic considerations on mucinous cystomas of the ovary based on histochemical and immunohistochemical findings].
Lapertosa G
Pathologica; 1989; 81(1074):381-401. PubMed ID: 2696922
[TBL] [Abstract][Full Text] [Related]
16. "Piling up" clear cells in müllerian-type mucinous and mixed cell-type borderline tumor do not represent concomitant clear cell neoplasms.
Ohishi Y; Kurihara S; Aman M; Takeuchi T; Imamura H; Kaku T; Kobayashi H; Wake N; Oda Y
Hum Pathol; 2012 Oct; 43(10):1618-26. PubMed ID: 22436624
[TBL] [Abstract][Full Text] [Related]
17. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
19. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localisation of carcinoembryonic antigen (CEA) in malignant epithelial ovarian tumours using monoclonal antibodies.
Gogate N; Deshmukh S
Indian J Pathol Microbiol; 1995 Apr; 38(2):199-201. PubMed ID: 8919110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
